JP2024535009A5 - - Google Patents
Info
- Publication number
- JP2024535009A5 JP2024535009A5 JP2024515936A JP2024515936A JP2024535009A5 JP 2024535009 A5 JP2024535009 A5 JP 2024535009A5 JP 2024515936 A JP2024515936 A JP 2024515936A JP 2024515936 A JP2024515936 A JP 2024515936A JP 2024535009 A5 JP2024535009 A5 JP 2024535009A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- months
- nircevimab
- rsv
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163261117P | 2021-09-13 | 2021-09-13 | |
| US63/261,117 | 2021-09-13 | ||
| US202263266594P | 2022-01-10 | 2022-01-10 | |
| US63/266,594 | 2022-01-10 | ||
| US202263363633P | 2022-04-26 | 2022-04-26 | |
| US63/363,633 | 2022-04-26 | ||
| US202263364554P | 2022-05-11 | 2022-05-11 | |
| US63/364,554 | 2022-05-11 | ||
| PCT/US2022/076311 WO2023039584A2 (en) | 2021-09-13 | 2022-09-12 | Prevention of respiratory syncytial virus lower respiratory tract infection with nirsevimab |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535009A JP2024535009A (ja) | 2024-09-26 |
| JP2024535009A5 true JP2024535009A5 (cg-RX-API-DMAC7.html) | 2025-09-26 |
Family
ID=83508746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515936A Pending JP2024535009A (ja) | 2021-09-13 | 2022-09-12 | ニルセビマブによる呼吸器合胞体ウイルス下気道感染の予防 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250340622A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4402166A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024535009A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240055097A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022341188A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3229901A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL310974A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202340237A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023039584A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS60387B1 (sr) | 2014-01-15 | 2020-07-31 | Medimmune Llc | Rsv-specifična antitela i njihovi funkcionalni delovi |
| US12024553B2 (en) * | 2019-04-30 | 2024-07-02 | Medimmune Limited | Dosage regimens for and compositions including anti-RSV antibodies |
-
2022
- 2022-09-12 KR KR1020247011813A patent/KR20240055097A/ko active Pending
- 2022-09-12 TW TW111134404A patent/TW202340237A/zh unknown
- 2022-09-12 IL IL310974A patent/IL310974A/en unknown
- 2022-09-12 AU AU2022341188A patent/AU2022341188A1/en active Pending
- 2022-09-12 WO PCT/US2022/076311 patent/WO2023039584A2/en not_active Ceased
- 2022-09-12 CA CA3229901A patent/CA3229901A1/en active Pending
- 2022-09-12 US US18/691,361 patent/US20250340622A1/en active Pending
- 2022-09-12 EP EP22783259.9A patent/EP4402166A2/en active Pending
- 2022-09-12 JP JP2024515936A patent/JP2024535009A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020002144A (ja) | 小児における急性呼吸促迫症候群の治療のための吸入一酸化窒素ガスを使用する方法 | |
| Tal et al. | Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial | |
| Wang et al. | A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia | |
| BERGEN | Appetite stimulating properties of cyproheptadine | |
| US20230201497A1 (en) | Method for pulsatile delivery of a gaseous drug | |
| JP2025510369A5 (cg-RX-API-DMAC7.html) | ||
| JPH05170647A (ja) | 睡眠中の換気を改善する方法および睡眠に係る換気異常を処置する方法 | |
| CN114504578A (zh) | 治疗、预防由病毒感染引起的相关疾病的药物及其用途 | |
| JP2022531205A5 (cg-RX-API-DMAC7.html) | ||
| Takiguchi et al. | Fulminant Mycoplasma pneumoniae pneumonia | |
| Zielecki et al. | Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab | |
| Sandritter et al. | Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: part I | |
| JP2019504040A (ja) | 中等度〜重度のインフルエンザの処置 | |
| Bentlin et al. | Sildenafil for pulmonary hypertension treatment after cardiac surgery | |
| BR112020010878A2 (pt) | tratamento de rsv com produto de combinação | |
| Miledge et al. | Instructive Case Pneumocystis carinii pneumonia as a presenting feature of X-linked hyper-IgM syndrome. | |
| TW202245799A (zh) | 治療冠狀病毒感染及由其導致之發炎所誘發的肺損傷之方法 | |
| JP2023533658A5 (cg-RX-API-DMAC7.html) | ||
| EP3324993A1 (en) | Composition for treatment of rsv | |
| Wada et al. | Respiratory failure of Williams-Campbell syndrome is effectively treated by noninvasive positive pressure ventilation | |
| Alaoui-Inboui et al. | Mortality Associated With Viral Bronchiolitis in a Pediatric Department: A Retrospective Analysis | |
| Idle et al. | Treatment of angina pectoris with nifedipine | |
| Tungal et al. | 7 Acute Bronchiolitis | |
| Jugulete et al. | Severe form of COVID-19 in a neonate with resuscitated cardio-respiratory arrest-Case presentation | |
| Raitakari et al. | Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood |